CANARIA THERAPEUTICS, INC.

Profile

Company Names

CANARIA THERAPEUTICS, INC.

Addresses

601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL 35806

Phone Numbers

256-327-0566

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$24,611.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-07-01 
$2,832.00 
$23,100.00 
$20,268.00 
Equity 
1
2018-10-10 
$21,779.00 
$29,536.00 
$7,757.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
D 
BENTLEY 
EXECUTIVE OFFICER, DIRECTOR
SERINA THERAPEUTICS, INC.   |  CANARIA THERAPEUTICS, INC.
BARBARA 
 
FISK 
DIRECTOR
SERINA THERAPEUTICS, INC.   |  CANARIA THERAPEUTICS, INC.   |  IXPRESSGENES, INC.
J 
MILTON 
HARRIS 
EXECUTIVE OFFICER, DIRECTOR
SERINA THERAPEUTICS, INC.   |  EGEN, INC.   |  CANARIA THERAPEUTICS, INC.
JAMES 
R 
HUDSON, JR. 
DIRECTOR
SERINA THERAPEUTICS, INC.   |  CANARIA THERAPEUTICS, INC.
MIGUEL 
A 
LOYA 
DIRECTOR
SERINA THERAPEUTICS, INC.   |  CANARIA THERAPEUTICS, INC.
RANDALL 
W 
MOREADITH 
EXECUTIVE OFFICER, DIRECTOR
SERINA THERAPEUTICS, INC.   |  CANARIA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-06-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2020-06-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2020-03-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2019-07-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2018-10-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#